Page last updated: 2024-08-25

bendamustine hydrochloride and deoxycytidine

bendamustine hydrochloride has been researched along with deoxycytidine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Borchmann, P; Diehl, V; Engert, A; Schnell, R1
Dougherty, DW; Friedberg, JW1
Casini, M; Cavattoni, IM; Cortelazzo, S; Deola, S; Farsad, M; Mian, M; Pescosta, N1
Anderlini, P; Cheah, CY; Chihara, D; Fanale, MA; Fayad, LE; Fowler, NH; Hagemeister, FB; Horowitz, S; Nastoupil, LJ; Neelapu, SS; Nieto, Y; Oki, Y; Rodriguez, MA; Romaguera, JE; Samaniego, F; Sevin, A; Turturro, F; Wang, M; Westin, JR; Zhou, S1
Anastasia, A; Annechini, G; Bonfichi, M; Carlo-Stella, C; Castagna, L; Di Renzo, N; Giordano, L; Gotti, M; Liberati, AM; Luminari, S; Mazza, R; Merli, F; Peli, A; Pulsoni, A; Re, A; Salvi, F; Santoro, A; Zilioli, VR1
Anastasia, A; Annechini, G; Bonfichi, M; Carlo-Stella, C; Castagna, L; Di Renzo, N; Giordano, L; Gotti, M; Liberati, AM; Luminari, S; Mazza, R; Merli, F; Peli, A; Pulsoni, A; Re, A; Ricci, F; Santoro, A; Zanni, M; Zilioli, VR1

Reviews

2 review(s) available for bendamustine hydrochloride and deoxycytidine

ArticleYear
New drugs in the treatment of Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9 Suppl 5

    Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bendamustine Hydrochloride; Deoxycytidine; Drug Therapy; Gemcitabine; Hodgkin Disease; Humans; Idarubicin; Immunotoxins; Nitrogen Mustard Compounds; Vinblastine; Vinorelbine

1998
Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?
    Current hematologic malignancy reports, 2010, Volume: 5, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Histone Deacetylase Inhibitors; Hodgkin Disease; Humans; Lenalidomide; Nitrogen Mustard Compounds; Rituximab; Thalidomide; Vinblastine; Vinorelbine

2010

Trials

2 trial(s) available for bendamustine hydrochloride and deoxycytidine

ArticleYear
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 09-20, Volume: 34, Issue:27

    Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prospective Studies; Transplantation, Autologous; Vinblastine; Vinorelbine; Young Adult

2016
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma.
    Blood advances, 2020, 01-14, Volume: 4, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Deoxycytidine; Disease-Free Survival; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Recurrence; Transplantation, Autologous

2020

Other Studies

2 other study(ies) available for bendamustine hydrochloride and deoxycytidine

ArticleYear
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
    Annals of hematology, 2013, Volume: 92, Issue:1

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Female; Gemcitabine; Graft vs Host Disease; Hodgkin Disease; Humans; Ifosfamide; Male; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Recurrence; Reoperation; Rituximab; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Vinorelbine; Young Adult

2013
Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bendamustine Hydrochloride; Brentuximab Vedotin; Deoxycytidine; Disease Progression; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Immunoconjugates; Male; Middle Aged; Treatment Outcome

2016